Joseph Szustakowski, Ph.D., Bristol-Myers Squibb

Joseph Szustakowski, Ph.D. Dr. Joseph Szustakowski is the Executive Director and Head of Translational Bioinformatics at Bristol-Myers Squibb (BMS) where he leads a large team of computational biologists in the Translational Medicine division. Their work spans all therapeutic areas from discovery through clinical development.

Dr. Szustakowski received his undergraduate training in Physics (B.S.) and Math at the State University of New York at Buffalo, and Biomedical Engineering (Ph.D.) at Boston University. While in graduate school, Joseph served as a member of the Human Genome Project’s annotation team.

Following graduate school, Joseph joined Novartis in Cambridge, Massachusetts, where he held positions with increasing responsibility ending with service as Associate Director for marker data sciences at before joining BMS in 2015. During his time at BMS, he has built up the Translational Bioinformatics team, which has become a leader in the application of Next Generation Sequencing and related -omics technologies in clinical trials.


10:05 AM - 10:35 AM

AI Applications for Identifying New Drug Candidates

Your CEO knows the company needs to adopt AI/ML technology, but they don't want to get involved in the details.  You now have the budget, but you need to produce an ROI.  What are your options when it comes to using AI tools to identify new drug candidates?  AI has the potential to become an indispensable tool but only if the near-term ROI is realized.  What questions do you need to ask to get this right and make a difference in speed, cost and outcomes?



  • Adam West

    Adam West Director, Research Data Sciences and Engineering Eli Lilly and Company

Download Latest Agenda